Related Experiment Video
Updated: Apr 11, 2026

Antigenic Liposomes for Generation of Disease-specific Antibodies
Published on: October 25, 2018
Biologics and Novel Therapeutics in Food Allergy
Brent Anderson1, Claire Pascal1, M Gohazrua K Butler1
1Sean N. Parker Center for Allergy and Asthma Research, Stanford University, Stanford, Calif.
Abstract:
The US Food and Drug Administration approval of omalizumab for the treatment of food allergy has opened the door for therapeutics targeting the underlying mechanisms that drive food allergy. Here we discuss both approved and novel investigational therapeutic strategies targeting these allergic pathways for the treatment of food allergy.
More Related Videos
Related Concept Videos
Drug Products: Biologics, Biosimilars and Interchangeables
Inflammatory Bowel Disease IV: Pharmacological Management
Pharmacologic...
Allergic Drug Reactions
Allergic Reactions: Anaphylaxis
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Cross-reactivity

